Taiwan FDA registration 2024673fad1bd1c442f750e1e8aa5b74
Liquichek Maternal Serum II Control
TW: 立可測 母體血清品管液
Taiwan·Risk Class 2·MD·BIO-RAD LABORATORIES·Registered Mar 12, 2018 – Mar 12, 2028ActiveRegistration details
- Analysis ID
- 2024673fad1bd1c442f750e1e8aa5b74
- License Form
- Ministry of Health Medical Device Import No. 030520
- Customs Code
- DHA05603052000
Company information
- Manufacturer
- BIO-RAD LABORATORIES
- Manufacturer Country
- United States
- Authorized Representative
- Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.)
Product details
- Intended Use
- This product is a known concentration of quality control solution used to monitor the precision of laboratory test steps, and the analytes that can be monitored are AFP, Estriol (Free), hCG and inhibin-A.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Mar 12, 2018
- Expiry Date
- Mar 12, 2028
About this record
Access comprehensive regulatory information for Liquichek Maternal Serum II Control in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2024673fad1bd1c442f750e1e8aa5b74 and manufactured by BIO-RAD LABORATORIES. The authorized representative in Taiwan is Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices